Aspire Biopharma Holdings (ASBP) Other Non Operating Income (2025 - 2026)
Aspire Biopharma Holdings' (ASBP) quarterly Other Non Operating Income came in at $251807.0 in Q1 2026, up 365.29% year-on-year from $54118.1 in Q1 2025, and down 78.57% on a QoQ basis from $1.2 million in Q4 2025.
Aspire Biopharma Holdings (ASBP) Other Non Operating Income (2025 - 2026) Analysis & Trends
Aspire Biopharma Holdings (ASBP) has 2 years of Other Non Operating Income data on file, last reported at $251807.0 in Q1 2026.
- On a quarterly basis, Other Non Operating Income rose 365.29% year-over-year to $251807.0 in Q1 2026; TTM through Mar 2026 was $1.9 million, a N/A change from a year earlier, with the FY2025 full-year figure at $810787.0, changed N/A from the prior year.
- Other Non Operating Income for Q1 2026 stood at $251807.0, down from $1.2 million in the prior quarter.
- Over the last five years, Other Non Operating Income for ASBP reached as high as $1.2 million in Q4 2025 and fell as low as -$289401.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Aspire Biopharma Holdings | 1.21 Mn | -619,284.29 | 5,750.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 251,807.00 |
| Dec 31, 2025 | 1.17 Mn |
| Sep 30, 2025 | 775,062.00 |
| Jun 30, 2025 | -289,401.00 |
| Mar 31, 2025 | -94,917.00 |